IMAB Shares Outstanding History

Below is a table of the IMAB shares outstanding history going back to 1/17/2020:

Date IMAB Shares Outstanding

Also see: IMAB Market Cap History
Mouse over chart for data details
1/17/2020 ...1/17/2020
I-Mab is a holding company. Through its subsidiaries, Co. is primarily engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries. Co.'s drug pipeline includes: Felzartamab (TJ202), which is a monoclonal antibody directed against CD38; Eftansomatropin alfa (TJ101), which is a recombinant human growth hormone being developed as a therapy for growth hormone deficiency; Lemzoparlimab (TJC4), which is a CD47 monoclonal antibody discovered and developed internally by Co. for cancer immunotherapy; and Uliledlimab (TJD5), which is an inhibitory antibody against human CD73. We show 1 historical shares outstanding datapoints in our coverage of IMAB's shares outstanding history.

Understanding the changing numbers of IMAB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMAB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMAB by allowing them to research IMAB shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree IMAB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

IMAB Shares Outstanding History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.